These final results, together with a past report showing that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like actions in mice,2 support the notion of focusing on ACKR3 as a novel approach to modulate the opioid system, which could open up new therapeutic avenues for opioid-similar disorders. These outcomes recommend https://conolidine1theoriginalnat87643.is-blog.com/33211333/facts-about-conolidine-revealed